Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carlisle

356.03
-2.8500-0.79%
Volume:379.69K
Turnover:135.43M
Market Cap:15.36B
PE:13.03
High:359.84
Open:355.36
Low:354.23
Close:358.88
Loading ...

Carlisle Companies Inc: Fixing Number of Directors of Co at 11

THOMSON REUTERS
·
29 Jan

Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
29 Jan

1 big reason to buy CSL shares now

MotleyFool
·
29 Jan

Carlisle Keeps Quarterly Dividend at $1 a Share, Payable March 3 to Investors of Record Feb. 18

MT Newswires Live
·
29 Jan

Carlisle Companies Elects Sheryl D. Palmer to Its Board of Directors

THOMSON REUTERS
·
29 Jan

Carlisle Companies Declares Regular Quarterly Dividend

Business Wire
·
29 Jan

Carlisle Companies Elects Sheryl D. Palmer to its Board of Directors

Business Wire
·
29 Jan

CSL, PME or REA: Which ASX stock will be the first to hit $500?

LiveWire
·
28 Jan

APH Posts Strong Q4 Results: Is the Stock a Buy on Solid Guidance?

Zacks
·
24 Jan

U.S. RESEARCH ROUNDUP-Air Products & Chemicals, Brinker, Sherwin-Williams

Reuters
·
24 Jan

Is Carlisle Companies Incorporated (CSL) the Best Diversified Dividend Stock to Buy Now?

Insider Monkey
·
23 Jan

The CSL share price is down 14% from its 52-week high. Is it a buy?

MotleyFool
·
23 Jan

Press Release: Carlisle Companies to Announce Fourth Quarter 2024 Results on February 4, 2025

Dow Jones
·
22 Jan

Should you buy CSL and ResMed shares in January?

MotleyFool
·
22 Jan

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GlaxoSmithKline (GB:GSK), CSL (OtherCMXHF) and Opthea Limited (OtherCKDXF)

TIPRANKS
·
21 Jan

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AstraZeneca (GB:AZN), CSL (OtherCMXHF) and UCB SA (GB:0NZT)

TIPRANKS
·
21 Jan

Here's the earnings forecast out to 2029 for CSL shares

MotleyFool
·
21 Jan

Is Carlisle Companies (CSL) One of the Best Plastics and Rubber Stocks to Buy According to Analysts?

Insider Monkey
·
19 Jan

Jefferies Keeps Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
19 Jan

New CSL Bull Sees Growth Opportunities -- Market Talk

Dow Jones
·
17 Jan